116 related articles for article (PubMed ID: 21448950)
21. Correlation between choline and MIB-1 index in human gliomas. A quantitative in proton MR spectroscopy study.
Matsumura A; Isobe T; Anno I; Takano S; Kawamura H
J Clin Neurosci; 2005 May; 12(4):416-20. PubMed ID: 15925772
[TBL] [Abstract][Full Text] [Related]
22. [Proton magnetic resonance spectroscopy in the diagnosis of breast cancer].
Meladze NV; Kuchuk PV; Abduraimov AB; Les'ko KA; Shariia MA; Malik DS; Matkhev S; Boĭko EA
Vestn Rentgenol Radiol; 2011; (4):31-6. PubMed ID: 22288145
[TBL] [Abstract][Full Text] [Related]
23. Clinical application of magnetic resonance spectroscopy of the liver in patients receiving long-term parenteral nutrition.
Woodward JM; Priest AN; Hollingsworth KG; Lomas DJ
JPEN J Parenter Enteral Nutr; 2009; 33(6):669-76. PubMed ID: 19587386
[TBL] [Abstract][Full Text] [Related]
24. Study of lipid metabolism by estimating the fat fraction in different breast tissues and in various breast tumor sub-types by in vivo
Agarwal K; Sharma U; Mathur S; Seenu V; Parshad R; Jagannathan NR
Magn Reson Imaging; 2018 Jun; 49():116-122. PubMed ID: 29454110
[TBL] [Abstract][Full Text] [Related]
25. In vivo magnetic resonance spectroscopy of gynaecological tumours at 3.0 Tesla.
Booth SJ; Pickles MD; Turnbull LW
BJOG; 2009 Jan; 116(2):300-3. PubMed ID: 19076962
[TBL] [Abstract][Full Text] [Related]
26. In vivo quantification of the metabolites in normal brain and brain tumors by proton MR spectroscopy using water as an internal standard.
Tong Z; Yamaki T; Harada K; Houkin K
Magn Reson Imaging; 2004 Sep; 22(7):1017-24. PubMed ID: 15288143
[TBL] [Abstract][Full Text] [Related]
27. Granulomatous lesions in the breast presenting as carcinoma.
Milward TM; Gough MH
Surg Gynecol Obstet; 1970 Mar; 130(3):478-82. PubMed ID: 5461013
[No Abstract] [Full Text] [Related]
28. Characterization of neoplastic and normal human breast tissues with in vivo (1)H MR spectroscopy.
Kvistad KA; Bakken IJ; Gribbestad IS; Ehrnholm B; Lundgren S; Fjøsne HE; Haraldseth O
J Magn Reson Imaging; 1999 Aug; 10(2):159-64. PubMed ID: 10441019
[TBL] [Abstract][Full Text] [Related]
29. In vivo quantification of choline compounds in the breast with 1H MR spectroscopy.
Bolan PJ; Meisamy S; Baker EH; Lin J; Emory T; Nelson M; Everson LI; Yee D; Garwood M
Magn Reson Med; 2003 Dec; 50(6):1134-43. PubMed ID: 14648561
[TBL] [Abstract][Full Text] [Related]
30. Benign breast lesions that simulate malignancy: magnetic resonance imaging with radiologic-pathologic correlation.
Iglesias A; Arias M; Santiago P; Rodríguez M; Mañas J; Saborido C
Curr Probl Diagn Radiol; 2007; 36(2):66-82. PubMed ID: 17331838
[TBL] [Abstract][Full Text] [Related]
31. Proton (1H) MR spectroscopy of the breast.
Bartella L; Huang W
Radiographics; 2007 Oct; 27 Suppl 1():S241-52. PubMed ID: 18180230
[TBL] [Abstract][Full Text] [Related]
32. Correlation between Choline Peak at MR Spectroscopy and Calcium-Sensing Receptor Expression Level in Breast Cancer: A Preliminary Clinical Study.
Baio G; Rescinito G; Rosa F; Pace D; Boccardo S; Basso L; Salvi S; Calabrese M; Truini M; Neumaier CE
Mol Imaging Biol; 2015 Aug; 17(4):548-56. PubMed ID: 25613673
[TBL] [Abstract][Full Text] [Related]
33. Quantification of metabolites in breast cancer patients with different clinical prognosis using HR MAS MR spectroscopy.
Sitter B; Bathen TF; Singstad TE; Fjøsne HE; Lundgren S; Halgunset J; Gribbestad IS
NMR Biomed; 2010 May; 23(4):424-31. PubMed ID: 20101607
[TBL] [Abstract][Full Text] [Related]
34. Modified core wash cytology (CWC), an asset in the diagnostic work-up of breast lesions.
Wauters CA; Sanders-Eras MC; de Kievit-van der Heijden IM; Wesseling P; Venderink DJ; van Dijk Azn R; van den Wildenberg F; Kooistra BW; Strobbe LJ
Eur J Surg Oncol; 2010 Oct; 36(10):957-62. PubMed ID: 20708371
[TBL] [Abstract][Full Text] [Related]
35. Nonmass lesions in magnetic resonance imaging of the breast: additional T2-weighted images improve diagnostic accuracy.
Baltzer PA; Dietzel M; Kaiser WA
J Comput Assist Tomogr; 2011; 35(3):361-6. PubMed ID: 21586932
[TBL] [Abstract][Full Text] [Related]
36. Semi-quantitating stiffness of breast solid lesions in ultrasonic elastography.
Zhi H; Xiao XY; Yang HY; Wen YL; Ou B; Luo BM; Liang BL
Acad Radiol; 2008 Nov; 15(11):1347-53. PubMed ID: 18995186
[TBL] [Abstract][Full Text] [Related]
37. Comparison of choline and pharmacokinetic parameters in breast cancer measured by MR spectroscopic imaging and dynamic contrast enhanced MRI.
Su MY; Baik HM; Yu HJ; Chen JH; Mehta RS; Nalcioglu O
Technol Cancer Res Treat; 2006 Aug; 5(4):401-10. PubMed ID: 16866570
[TBL] [Abstract][Full Text] [Related]
38. (1)H MR spectroscopy with external reference solution at 1.5 T for differentiating malignant and benign breast lesions: comparison using qualitative and quantitative approaches.
Mizukoshi W; Kozawa E; Inoue K; Saito N; Nishi N; Saeki T; Kimura F
Eur Radiol; 2013 Jan; 23(1):75-83. PubMed ID: 22777619
[TBL] [Abstract][Full Text] [Related]
39. Clinical utility of proton magnetic resonance spectroscopy in characterizing breast lesions.
Katz-Brull R; Lavin PT; Lenkinski RE
J Natl Cancer Inst; 2002 Aug; 94(16):1197-203. PubMed ID: 12189222
[TBL] [Abstract][Full Text] [Related]
40. Quantification of choline-containing compounds in malignant breast tumors by 1H MR spectroscopy using water as an internal reference at 1.5 T.
Baik HM; Su MY; Yu H; Mehta R; Nalcioglu O
MAGMA; 2006 May; 19(2):96-104. PubMed ID: 16779565
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
